Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07556380 · ClinicalTrials.gov registry record · NA
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07556380: Recruiting NA study, sponsored by Northwestern University.
NCT07556380 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07556380, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.
Primary Outcome
Retention rates will be calculated for the overall study and separately for each component. Feasibility target: \<=30% treatment drop-out (or lost to follow-up) in at-least one treatment component. Investigators will report feasibility in aggregate and by site.
Interventions
- BEHAVIORAL Health Coaching
- BEHAVIORAL Action Planning
- BEHAVIORAL UV Real-Time Alerts
- BEHAVIORAL Track Your Sun Protection
- BEHAVIORAL Current Conditions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
What NCT07556380 shows while recruiting
NCT07556380 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 5 interventions - of which Health Coaching is the first listed.
NCT07556380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07556380 about?
NCT07556380 is a clinical study titled "Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions". The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposur...
What is the current status of trial NCT07556380?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-04-01. Estimated completion is 2027-09-01.
What interventions are being tested in trial NCT07556380?
The interventions under investigation include: Health Coaching (BEHAVIORAL), Action Planning (BEHAVIORAL), UV Real-Time Alerts (BEHAVIORAL), Track Your Sun Protection (BEHAVIORAL), Current Conditions (BEHAVIORAL).
Who is sponsoring clinical trial NCT07556380?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07556380's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI